AcelRx Pharmaceuticals Inc

ACRX 
(NASDAQ) 
 
$ 3.970
Updated 09:50:03
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 141
High $ 0
Low $ 3.670
Open $ 4.050
ISIN
Prev close $ 4.290
# of shares 60.60M
Market cap 240.58M USD
Intraday

Market closed
AcelRx Pharmaceuticals Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  3.97 10.4% Stock price increasing 15.1% Stock price increasing 32.3% Stock price increasing 76.4% Stock price increasing 126.9% Stock price increasing
Powered by TradingView

News about AcelRx Pharmaceuticals Inc

  • English
  • Regulatory news

Company profile

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company. It is focused on the development and commercialization of the therapies for the treatment of moderate to severe acute pain. Its main product candidates include Dsuvia, Zalviso, and ARX-04. The company generates the revenue from collaboration agreements which includes license fees, cost reimbursement, development and manufacturing services, payments and royalties.

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
17 October 2018 11:42:59
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20181005.3 - EUROWEB3 - 2018-10-17 12:42:59 - 2018-10-17 11:42:59 - 1000 - Website: OKAY